Literature DB >> 19332793

Caveolae are required for protease-selective signaling by protease-activated receptor-1.

Angela Russo1, Unice J K Soh, May M Paing, Puneeta Arora, Joann Trejo.   

Abstract

Protease-activated receptor-1 (PAR(1)) is a G-protein-coupled receptor uniquely activated by proteolysis. Thrombin, a coagulant protease, induces inflammatory responses and endothelial barrier permeability through the activation of PAR(1). Activated protein C (APC), an anti-coagulant protease, also activates PAR(1). However, unlike thrombin, APC elicits anti-inflammatory responses and protects against endothelial barrier dysfunction induced by thrombin. We found that thrombin and APC signaling were lost in PAR(1)-deficient endothelial cells, indicating that PAR(1) is the major effector of protease signaling. To delineate the mechanism responsible for protease-selective signaling by PAR(1), we examined the effect of APC and thrombin on the activation of RhoA and Rac1, small GTPases that differentially regulate endothelial barrier permeability. Thrombin caused robust RhoA signaling but not Rac1 activation, whereas APC stimulated a marked increase in Rac1 activation but not RhoA signaling, consistent with the opposing functions of these proteases on endothelial barrier integrity. Strikingly, APC signaling and endothelial barrier protection effects were abolished in cells lacking caveolin-1, whereas thrombin signaling remained intact. These findings suggest that compartmentalization of PAR(1) in caveolae is critical for APC selective signaling to Rac1 activation and endothelial barrier protection. We further report that APC induces PAR(1) phosphorylation and desensitizes endothelial cells to thrombin signaling but promotes limited receptor cleavage and negligible internalization and degradation even after prolonged APC exposure. Thus, APC selective signaling and endothelial barrier protective effects are mediated through compartmentalization of PAR(1) in caveolae and a novel mechanism of PAR(1) signal regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332793      PMCID: PMC2669384          DOI: 10.1073/pnas.0810687106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.

Authors:  F B Taylor; D J Stearns-Kurosawa; S Kurosawa; G Ferrell; A C Chang; Z Laszik; S Kosanke; G Peer; C T Esmon
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

2.  Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference.

Authors:  Sebastian Schuck; Aki Manninen; Masanori Honsho; Joachim Füllekrug; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

3.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

4.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor.

Authors:  Laurent O Mosnier; John H Griffin
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

6.  Permanent cell line expressing human factor VIII-related antigen established by hybridization.

Authors:  C J Edgell; C C McDonald; J B Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.

Authors:  May M Paing; Amy B Stutts; Trudy A Kohout; Robert J Lefkowitz; JoAnn Trejo
Journal:  J Biol Chem       Date:  2001-11-02       Impact factor: 5.157

8.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

9.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.

Authors:  C Tiruppathi; W Yan; R Sandoval; T Naqvi; A N Pronin; J L Benovic; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

10.  Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Authors:  Matthias Riewald; Ramona J Petrovan; Aaron Donner; Barbara M Mueller; Wolfram Ruf
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

View more
  77 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  β-Arrestin and dishevelled coordinate biased signaling.

Authors:  Gunnar Schulte; Sudha K Shenoy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

3.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

Review 4.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

5.  Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.

Authors:  Ranjeet K Sinha; Xia V Yang; José A Fernández; Xiao Xu; Laurent O Mosnier; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-21       Impact factor: 8.311

6.  Cell painting with an engineered EPCR to augment the protein C system.

Authors:  Eveline A M Bouwens; Fabian Stavenuiter; Laurent O Mosnier
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

7.  Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo.

Authors:  Laura D Healy; Cristina Puy; José A Fernández; Annachiara Mitrugno; Ravi S Keshari; Nyiawung A Taku; Tiffany T Chu; Xiao Xu; András Gruber; Florea Lupu; John H Griffin; Owen J T McCarty
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

8.  Protein C receptor stimulates multiple signaling pathways in breast cancer cells.

Authors:  Daisong Wang; Chunye Liu; Jingqiang Wang; Yingying Jia; Xin Hu; Hai Jiang; Zhi-Ming Shao; Yi Arial Zeng
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

9.  Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.

Authors:  Amal Arachiche; Michele M Mumaw; María de la Fuente; Marvin T Nieman
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

10.  Evaluation of antibodies directed against human protease-activated receptor-2.

Authors:  Mark N Adams; Charles N Pagel; Eleanor J Mackie; John D Hooper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-31       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.